Gyrus to buy LivaNova’s heart valve business

Gyrus Capital has agreed to acquire LivaNova's heart valve business.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this